Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Sirona Biochem Corp > Working for the V's
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1167)
•••
Comment by Pandoraon Sep 09, 2024 1:07am
86 Views
Post# 36214223

RE:RE:Working for the V's

RE:RE:Working for the V's
lscfa wrote: Christopher Verrico ceased to be an insider Nov 27, 2013. Damn fool must have filed an incorrect insider report or SBM has hired him back as a director and not disclosed it yet.


From the "Ownership" tab near the top of the page:

 
  Date
 
 
 Name
 
 
 Shares Traded
 
 
 Value
 
 
 Shares Held
 
 
 Filing Type
 
 
 
2024-03-11
Verrico (Christopher R)
16,000
$0.00
1,574,539
SEDI
 
2024-02-19
Verrico (Howard)
450,000
$0.00
9,855,695
SEDI
 
 
Verrico (Howard)
--
$0.00
--
 

From the "Insiders" tab near the top of the page:

  Date
 
 
 Name
 
 
 Shares Traded
 
 
 Value
 
 
 Shares Held
 
 
 Filing Type
 
 
 
2024-03-11
Verrico (Christopher R)
16,000
$0.00
1,574,539
SEDI
 
2024-02-19
Verrico (Howard)
450,000
$0.00
9,855,695
SEDI
 
 
Verrico (Howard)
--
$0.00
 

It seems strange there is nothing since March of 2024 and it also seems strange there is nothing for Chris Hopton.

I have no idea how or how often Stockhouse gets this data updated.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities